Showing results (21-30 of 39) with videos related to
Sort By:
Pageof 4
Journal of Chromatography|April 11, 1977
Epoxide-diol metabolic pathway of cytenamide in the ratA Frigerio, J Lanzoni, C Pantarotto, et al.Journal of Chromatography|April 10, 1981
Determination of antrafenine and its main acid metabolite, 2-{[7-(trifluoromethyl)-4-quinolinyl]amino}-benzoic acid, in biological fluids using high-performance liquid chromatography with large volume automatic injection and gas-liquid chromatography with derivative formationP R Guinebault, M Broquaire, M Sanjuan, et al.Biochemical Pharmacology|August 1, 1983
Plasma protein binding of the reversible type A MAO inhibitor cimoxatone (MD 780515)V Rovei, F Chanoine, M Strolin Benedetti, et al.The Journal of Pharmacology and Experimental Therapeutics|April 1, 1996
Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. I. Biochemical profileO Curet, G Damoiseau, N Aubin, et al.Il Farmaco; Edizione Scientifica|November 1, 1975
Mass spectrometric identification of 10,11-dihydro-10,11-dihydroxyprotriptyline in rat urine after administration of protriptylineG Belvedere, A Frigerio, C Pantarotto, et al.Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|March 1, 2016
Large randomized trial comparing transabdominal ultrasound-guided embryo transfer with a technique based on uterine length measurement before embryo transferA Revelli, V Rovei, P Dalmasso, et al.Clinical Pharmacology and Therapeutics|October 1, 1992
Pharmacokinetic and pharmacodynamic interaction between toloxatone, a new reversible monoamine oxidase-A inhibitor, and oral tyramine in healthy subjectsJ C Provost, C Funck-Brentano, V Rovei, et al.Therapeutic Drug Monitoring|January 1, 1980
Preliminary observations of the significance of monitoring tricyclic antidepressant plasma levels in the pediatric patientM Dugas, E Zarifian, M F Leheuzey, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 26, 2006
Fertility in patients with multiple sclerosis: current knowledge and future perspectivesP Cavalla, V Rovei, S Masera, et al.European Journal of Clinical Pharmacology|January 1, 1988
The pharmacokinetics of bendazac-lysine and 5-hydroxybendazac, its main metabolite, in patients with hepatic cirrhosisV Rovei, J Escourrou, G Campistron, et al.Pageof 4